Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Neonatal-Perinatal Physicians (US)

Analysis of: FDA Approves Nexium for Use in Children Ages 1-11 Years (pharmalive.com)
As is the case with choice of PPI's in adult patients, in pediatrics we now have a large number of effective drugs from which to choose. However, "managed care" policies limit the choices and make the prescribing of newer products problematic.
Analysis of: Drug Pitchmen: Actor, Doctor or Pfizer’s Option (www.nytimes.com)
Why is the Jarvik ad campaign any more offensive than the famous line quoted above? If any direct-to-consumer (DTC) advertising is acceptable, then why is there any furor over the use of actors who are not technically qualified as pitchmen?
March 6, 2008
An Unhappy Trend
Analysis of: Your Hospital's Deadly Secret (www.portfolio.com)
As hospitals outsource everything, from laboratory management to emergency rooms to pharmacies, control of these areas is being lost, often to the detriment of patients.
Analysis of: Intercell completes Phase I clinical trial for improved seasonal Flu vaccine formulated with IC31(R) (www.pipelinereview.com)
While new adjuvants always hold promise, and Intercell's product seems to be efficacious without undue reactogenicity, any vaccine is only as good as its raw materials. This year's flu vaccine's lack of efficacy is a case in point.
Analysis of: As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years, Technology will be Called upon to Stem the Tide (biz.yahoo.com)
New technology is one factor in the ever-increasing cost of healthcare.  New medical technologies  are seldom cost-saving.
Analysis of: Vaccinating Boys for Girls’ Sake? (www.nytimes.com)
While the disease incidence (cervical carcinoma) is lower than many other cancers, thanks in part to successful screening, many of the remaining cases could be prevented by vaccinating EVERY female prior to the onset of sexual activity. Since this universal coverage is not likely, vaccinating males...
Analysis of: Google to store patients' health records (news.yahoo.com)
Eventually, although not likely in the next ten years, electronic medical records (EMRs) will be the norm; once the interoperability issues are addressed, these records will be sharable across various networks. Until that time, systems such as Google's might serve some purpose.   &nb...
Analysis of: Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia (pharmalive.com)
The alpha adrfenergic side effects of current treatments for BPH are significantly limiting in the use of these drugs.
Analysis of: Phosphagenics Initiates US Clinical Trials For Its Topical Retinoic Acid (www.pipelinereview.com)
Novel delivery systems will generally be the next wave, whether for topical medications such as retinoic acid or systemic compounds, where the delivery system can target specific receptors or organs.
Analysis of: Memphis Chosen by HHS as One Community to Help Create "Travelocity of Health Care" (www.memphis.bizjournals.com)
Rating physicians is not like rating hotels, airlines or restaurants. Unfortunately, the comments of lay people can only go so far in assessing a physician's performance.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next71 to 80 of 159

Analytics


Generated at 2009-01-07T07:00:32.297